临床荟萃

• 病例报告 • 上一篇    下一篇

c.10063C>G突变致鸟氨酸氨甲酰基转移酶缺乏症1例及文献复习

  

  1. 新乡医学院第一附属医院 PICU, 河南 新乡 453100
  • 出版日期:2019-09-20 发布日期:2019-11-19
  • 通讯作者: 李树军,Email:lishujun772@sina.com

A case report and  literature review:ornithine transcarbamylase deficiency caused by mutation of c.1006-3c>G#br#

  1. PICU, the First Affiliated Hospital of Xinxiang Medical College,  Xinxiang 453100, China
  • Online:2019-09-20 Published:2019-11-19
  • Contact: Corresponding author: Li Shujun, Email:lishujun772@sina.com

摘要: 患儿以消化系统为首要症状起病,因血氨过高导致颅内出血、脑死亡。住院期间行基因检测结果提示由c.10063C>G突变所致。本病临床表现缺乏特异性,主要依靠血尿的串联质谱分析,以及本病诊断金标准基因检测进行诊断。鸟氨酸氨甲酰基转移酶缺乏症(OTCD)患者病死率高,预后很差,目前尚无临床标准治疗方案,临床医师需提高对其认识和诊断、治疗水平,早期发现高血氨,早期进行血液净化技术可能会缓解症状。

关键词: 鸟氨酸氨甲酰转移酶缺乏症, 高氨血症, 蛛网膜下腔出血, 基因检测

Abstract: The child started  with digestive system discomfort as the primary symptom,resulting in intracranial hemorrhage and brain death  due to high blood ammonia.The results of gene test during hospitalization indicated that the mutation ofc.10063C>G  was responsible.  The clinical manifestation of this disease is lack of specificity,mainly relying on the tandem mass spectrometry analysis of hematuria,and the gold standard(genetic detection)for the diagnosis of the disease. Ornithine transcarbamylase deficiency(OTCD)  patients  have a high mortality rate  and a poor prognosis.There is no clinical standard  treatment  plan at present.Clinicians need to improve the awareness,diagnosis,treatment level,andearly detection of high blood ammonia.Early blood  purification  techniques may alleviate symptoms.

Key words: ornithine carbamoyltransferase deficiency disease, hyperammonemia, subarachnoid hemorrhage, genetic testing